Alex Keun Mo Yang insider trades
Open-market stock purchases and sales by Alex Keun Mo Yang, Chief Executive Officer at Polaryx Therapeutics, Inc, from SEC Form 4 filings since May 27, 2026.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -40%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 27, 2026 | PLYX Polaryx Therapeutics, Inc | Bought | $360K |
Companies traded
- PLYX Polaryx Therapeutics, Inc: 1 buy, last May 27, 2026